Quintet Private Bank (Europe) S.A. Biogen Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.72 Trillion
- Q2 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 647 shares of BIIB stock, worth $122,108. This represents 0.01% of its overall portfolio holdings.
Number of Shares
647
Previous 341
89.74%
Holding current value
$122,108
Previous $84.5 Million
104.36%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BIIB
# of Institutions
1,049Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.13 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.08 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.74 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.34 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.07 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $27.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...